Followers | 96 |
Posts | 4824 |
Boards Moderated | 0 |
Alias Born | 02/07/2021 |
Saturday, May 18, 2024 11:37:24 PM
As much as we all speculate arguing back and forth on timelines we know nontoxic life-saving treatments will be approved for orphan cancer patients. If MHRA deliver approval this week or next let's all congratulate the tens of thousands of patients which will live longer lives through DCVax.
When I was only 16 my mother nearly died from breast cancer which drew to this sector of investing as an adult. We all wish this was completed years ago but remember the average time to bring a run of the mill drug to market happens to be over a decade at an average cost of $2B!
[B]We do not own discretionary consumer goods with few barriers to market entry!
After JAMA, MIA, Nature, and endless patent approvals, now isn't the time to panic or be upset. Let regulators finalize their process however quickly or drawn out that may be the result will be approval. All longs regardless of their cost average will see immense upside.
Love to you and yours I hope they never suffer this terrible disease!
We stand united behind this paradigm-changing company.
Most difficult challenge with $NWBO's DCVax was manufacturing the personalized autologous vaccine in cost-effective manner at scale to meet global demand not whether regulators would approve nontoxic life-saving treatment for orphan Glioblastoma patients.
— autologous assassin 🇺🇸 🇺🇦 🇮🇱 (@flaskworks) May 18, 2024
Do your own research. I am not providing legal or investment advice. Nothing I say should be considered solicitation to buy or sell any security. This is an anonymous forum for entertainment purposes only. Do not trust anything you read.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM